Duane retraction syndrome (DRS) is the most common form of congenital paralytic strabismus in humans and can result from α2-chimaerin (CHN1) missense mutations. We report a knockin α2-chimaerin mouse (Chn1 abducens neurons use bidirectional ephrin signaling via mutant α2-chimaerin to direct growth, while cervical spinal neurons use only ephrin forward signaling, and trochlear neurons do not use ephrin signaling. These findings reveal a role for ephrin bidirectional signaling upstream of mutant α2-chimaerin in DRS, which may contribute to the selective vulnerability of abducens motor neurons in this disorder.
Introduction
Despite the complexity of axon guidance during neurodevelopment and its importance for proper circuit formation and normal behavior, few human disorders have been shown with certainty to result from abnormalities in this process. The precise alignment and coordinated movement of the eyes create a sensitive system to identify pathologic innervation of the extraocular muscles (EOMs) that arises during development (1, 2) . Neurogenic forms of strabismus serve as models to investigate axon guidance mechanisms that are relevant to human development.
The ocular motor system comprises the oculomotor, trochlear, and abducens cranial nerves, which project to 7 EOMs (3) (Supplemental Figure 1A ; supplemental material available online with this article; https://doi.org/10.1172/JCI88502DS1). Duane retraction syndrome (DRS) is a form of paralytic strabismus that results from altered ocular motor circuitry. Affected individuals cannot move one or both eyes laterally toward the ear (limited abduction), and upon attempted medial eye movement toward the nose (adduction), the globe(s) retract into the orbit. Autopsy, MRI, and electromyography studies of affected individuals have revealed loss of abducens motor neurons and nerve, which normally innervates the lateral rectus muscle to abduct the eye (4) (5) (6) , and aberrant innervation of the lateral rectus by axons from the oculomotor nerve, which causes co-contraction of the medial and lateral recti on attempted adduction and retraction of the globe into the orbit (5-7) (Supplemental Figure 1B ).
Genetic studies of pedigrees segregating DRS as an autosomal dominant trait identified gain-of-function missense mutations in CHN1 that enhance the normal activity of the encoded protein α2-chimaerin (3, 8, 9) . α2-Chimaerin-encoding mRNA is expressed in nearly all central and peripheral developing neurons in rodent embryos (10) and displays widespread neuronal expression at Carnegie stage 15/16 in developing human embryos, including rhombomere 5, where abducens neurons are located (3) . Remarkably, despite broad neuronal expression of α2-chimaerin, the phenotype of affected individuals with CHN1 mutations is limited to disordered eye movements. While clinical data and CHN1 mutations support a neurogenic rather than myogenic etiology for DRS (3, 4, 9) , the precise cellular and molecular mechanisms underlying its neurogenic etiology remain unknown.
α2-Chimaerin is a Rac GTPase-activating protein (RacGAP) reported to regulate cytoskeletal dynamics (11) (12) (13) (14) (15) and exists in an autoinhibited form until it is recruited to the plasma membrane and activated by upstream signaling (16, 17) . Once activated, the α2-chimaerin GAP domain induces hydrolysis of Rac-GTP to inactive Rac-GDP, which alters actin dynamics and generates growth cone collapse (12) (13) (14) 16) . Reported human CHN1 mutations enhance RacGAP activity to further reduce Rac-GTP levels when overexpressed in heterologous cells (3, 9) . α2-Chimaerin is reported to act downstream of several receptors implicated in axon growth and guidance, including EPH receptor A4 (EphA4), TrkB, and neu-mice to Isl MN -GFP reporter mice -an allele of the ISL1 transcripropilin 1/plexinA (11) (12) (13) (14) (15) (16) 18) . Epha4 KO/KO and Chn1 KO/KO adult mice have a rabbit-like hopping gait, resulting from aberrant re-crossing of the corticospinal tract and miswiring of spinal interneurons that regulate central pattern generator (CPG) circuitry within the spinal cord (12, 14, 15, (19) (20) (21) (22) . α2-Chimaerin, furthermore, has been shown to interact with phosphorylated residues on EphA4 to alter cytoskeletal dynamics and elicit growth cone collapse (12, 13, 15) .
Overexpression of DRS-mutant α2-chimaerin in the oculomotor nerve of chick and zebrafish was reported to cause oculomotor nerve stalling and/or branching defects (3, 18, 23) . The primary DRS phenotype, however, was recently shown to arise from developmental absence of the abducens nerve and the subsequent ectopic innervation of its lateral rectus muscle target by the oculomotor nerve (24) . These data suggest that CHN1 mutations are more likely to cause primary defects in abducens rather than oculomotor nerve development. Thus, the developmental etiology and molecular mechanisms underlying DRS in the abducens and oculomotor nerves in the presence of endogenously hyperactive α2-chimaerin required further investigation.
Here, we establish a Chn1 mutant knockin mouse model of DRS and find that Chn1 mutations alter the primary development of the abducens, trochlear, and C1 nerves. Mechanistically, we find that these three different motor neuron populations harness ephrin/EphA4-mediated signaling pathways upstream of mutant α2-chimaerin in distinct manners to guide developing axons. Our data illustrate the neurodevelopmental pathology and etiology of DRS, provide insight into the selective vulnerability of the abducens nerve to gain-of-function α2-chimaerin mutations, and highlight the complexity of motor neuron guidance.
Results

α2-Chimaerin mutations in DRS are gain-of-function and alter abducens nerve development.
To investigate the etiology of DRS, we generated a Chn1-knockin mouse model harboring an L20F amino acid substitution (Chn1
KI/KI
), which is specific to the α2 isoform of chimaerin. This substitution segregated in a family with DRS and, following activation with PMA, enhanced α2-chimaerin membrane translocation, dimerization of WT and mutant α2-chimaerin, and RacGAP activity in vitro (3) . We flanked exon 3 of the knockin construct with LoxP sites to permit generation of a conditional α2-chimaerin-knockout mouse upon exposure to Cre-recombinase (Chn1
KI/KI mice were born at the expected Mendelian frequency, were fertile, and had a normal lifespan.
In order to determine whether α2-chimaerin was constitutively active in neurons under endogenous expression of mutant protein, we cultured cortical neurons to assess Rac-GTP levels. We found that Rac-GTP levels did not differ between Chn1
WT/WT and Chn1 KI/KI cultured cortical neurons without stimulation, demonstrating that α2-chimaerin is not constitutively active in cortical neurons. However, upon addition of PMA to broadly activate α2-chimaerin irrespective of upstream pathway activation, mutant cultures had a marked reduction in Rac-GTP levels compared with WT cultures, demonstrating that the endogenous L20F amino acid substitution enhances GAP activity of α2-chimaerin upon activation (Supplemental Figure 1F ), similar to previous overexpression experiments in non-neuronal cells (3, 9). innervated by one or two aberrant oculomotor nerve branches arising at established oculomotor growth cone decision regions (27) : the proximal branch formed from the superior oculomotor nerve division branch-point off the main oculomotor trunk, while the distal branch arose from the inferior oculomotor nerve division branch-point to the medial rectus, inferior rectus, and inferior oblique muscles ( Figure 2B ). Thus, the oculomotor nerve provides compensatory misinnervation to the lateral rectus in the absence of the abducens nerve, confirming human autopsy and electromyographic data. In Chn1 KO/KO embryos, the lateral rectus received innervation from the abducens nerve, and there was no stalling or aberrant branching of the oculomotion factor gene fused to GFP and tagged with a Ras farnysylation sequence for membrane localization (28) -in order to visualize all cranial motor nuclei and nerve projections and determine whether Chn1 KI/KI mice exhibit misinnervation by the oculomotor nerve. In WT embryos, the abducens nerve crossed the oculomotor nerve in close proximity to the lateral rectus prior to its innervation ( Figure 2A ). The abducens nerve was absent from the orbit in E16.5 Chn1 KI/KI embryos, consistent with primary stalling rather than delayed outgrowth as the cause of the initial lateral rectus innervation deficit ( Figure 2B ). While the oculomotor nerve had a normal trajectory to the orbit (Figure 1 , D and E, and Supplemental Videos 1 and 2), the lateral rectus was subsequently KI/KI mice, we predicted abducens motor neurons would undergo subsequent apoptosis due to lack of trophic support. Indeed, while the number of Chn1 KI/KI abducens motor neurons was not significantly different from WT at E10.5 immediately prior to abducens stalling ( Figure 2D ), the number was greatly reduced compared with WT by E13.5, 2 days after the abducens phenotype was observed (Figure 2, E and F) . To deter- L, and Figure 2B ). These data support primary abducens nerve stalling at E11.5, failure of lateral rectus target innervation, and subsequent secondary abducens motor neuron apoptosis by E13. KO/KO and Epha4 KO/KO mice aberrantly cross the spinal cord midline, as their axons lack responsiveness to ephrin midline repellents (12, 14, 15, 21) . We hypothesized that gain-of-function Chn1 KI mutations could act downstream of EphA4 to increase repulsion to ephrins and further enhance growth cone collapse ( Figure 3A) . We used abducens explant cultures to assess growth cone collapse and axon retraction in response to ephrin-A and -B guidance factors in vitro. Abducens neurons exhibited significant growth cone collapse and axon retraction upon bath application of recombinant ephrin-A5 and ephrin-B1 and trended toward collapse and retraction with ephrin-B2 (Figure 3 , B-E, and Supplemental Video 4).
Using an ephrin-A5-AP binding assay, we found that ephrin-A5 bound to the abducens nucleus at E11.5 ( Figure 3F ). We focused specifically on the involvement of EphA4 in ephrin-mediated binding and repulsion because α2-chimaerin is reported to act downstream of EphA4 and not EphB isoforms (13, 29) . In situ hybridization (ISH) in E11.5 embryos revealed Epha4 expression in abducens motor neurons ( Figure 3G ). We reasoned that if ephrin/EphA4 signaling is the main regulator of abducens development upstream of α2-chimaerin, we could expect Epha4 KO (D) embryos. n = 10 nerves (5 embryos) for all genotypes; arrowhead, exited abducens nerve bundles counted in E; white arrow, location of abducens stalling measured in F; yellow arrow, location of abducens diameter at orbit measured in G; red, neurofilament; green, Hb9-GFP. (E-H) Number of abducens nerve bundles at hindbrain exit (E); abducens length from hindbrain exit to most distal projection (F); abducens diameter at orbit (G); and number of wandering abducens nerve bundles (H) as measured from transverse images in M-P. *P < 0.05, **P < 0.01, ***P < 0.001, 1-way ANOVA with Tukey's test; data represent mean ± SEM. C, Chn1; A4, Epha4. (I-L) Abducens fasciculation with mandibular and cervical branches of the facial nerve in E11. WT/KI (bottom row) Hb9-GFP-positive abducens nucleus explants grown in 50 ng/ml FC without growth factor (C and D) or with 50 ng/ ml FC+25 ng/ml GDNF (E and F), 50 ng/ml ephrin-A5+25 ng/ml GDNF (G and H), or 1 μg/ml EphA4+25 ng/ml GDNF (I and J). Scale bars: 100 μm. : n = 19, 6 experiments) (P). (Q and R) Quantification of average maximum outgrowth (Q) and total outgrowth (R) from N-P. †P < 0.07, *P < 0.05, ***P < 0. Figure 1I and Figure 3I ). ; aberrant fascicles wandered more; and some aberrant fascicles tracked with the mandibular and cervical branches of the facial nerve, rather than the buccal branch. Moreover, E13.5 Epha4 KO/KO embryos had approximately half the number of abducens motor neurons than WT embryos (Supplemental Figure 3 , B and C), consistent with survival of only those motor neurons whose axons successfully reached the EOM anlage within area 3. These results confirm that EphA4 signaling is important for proper abducens nerve development and may act within an α2-chimaerin-mediated pathway.
Abducens : n = 10, 3 experiments) (K). (L and M) Quantification of average maximum outgrowth (L) and total outgrowth (M) from H and K. Scale bars: 100 μm. † P < 0.07, *P < 0.05, **P < 0.01, ***P < 0. (Figure 4 , F-H), there was a trend toward reduced abducens nerve diameter at the orbit, which appeared to result from a higher incidence of orbital innervation failure (2 of 5 embryos, Figure 4E ). Compared with Chn1 KO/KO Epha4 WT/KO embryos, the double mutants had significantly reduced abducens nerve length and diameter at the orbit (Figure 4, F and G) . Thus, while Cre/+ abducens nerve in sagittal (G) and transverse views (H); arrows, stalled nerve bundles after exit from area 1; n = 3 embryos. nVI, abducens nucleus; O, orbit; red, neurofilament; green, Hb9-GFP. Scale bars: 100 μm. (I-L) Number of exited abducens nerve bundles (I), abducens nerve length (J), abducens diameter at orbit (K), and wandering abducens nerve bundles (L) for indicated genotypes; *P < 0.05, **P < 0.01, ***P < 0. Figure 1F) , it remained possible that mutant α2-chimaerin was constitutively hyperactive in abducens neurons irrespective of receptor activation. Second, it is possible that mutant α2-chimaerin was not constitutively active, but could be recruited to full hyperactivity downstream of a nonEphA4 pathway. Either scenario would be predicted to result in mental area of the abducens nerve (as outlined in Figure 1G ), supporting both EphA4-and non-EphA4 receptor-meditated pathways upstream of α2-chimaerin and absence of constitutive activation. Upon nerve exit in area 1 ( Figure 1G) The complex genetic interaction between α2-chimaerin and EphA4 in the abducens nerve of our double mutant crosses led us to ask whether abducens neurons use bidirectional EphA4 signaling upstream of α2-chimaerin to guide development. Epha4 and ephrin-A5 expression at E11.5 supported this possibility: Epha4 was expressed in the orbital EOM anlage, which was the targeted innervation area of the abducens nerve ( Figure 6A ), while ephrin-A5 was expressed in E11.5 abducens neurons ( Figure 6B and Supplemental Figure 4A ), suggesting EphA4 may be used as a ligand to mediate attraction via neuronally expressed ephrin.
In order to test the effects of ephrin forward and reverse signaling on abducens outgrowth, we developed a modified Sholl analysis approach to compare maximum outgrowth (average maximum neurite distance) and total outgrowth (average area under the entire curve) of WT and mutant embryonic abducens explants maintained in culture with recombinant growth factors and/or guidance cues (Supplemental Figure 4 , B and C). There were no differences in outgrowth between Chn1
WT/WT and Chn1 WT/KI abducens explants cultured without growth factors, demonstrating again that mutant α2-chimaerin is not constitutively hyperactive at baseline (Figure 6 , C, D, and K-M).
For ephrin signaling experiments, abducens explants were grown in GDNF because explants grown in ephrin-A5 without growth factor displayed extremely diminished levels of outgrowth (Supplemental Figure 4, D-H) . Explants grown in EphA4 alone displayed slightly increased outgrowth, similar to previous reports of spinal motor neurons (32) (Supplemental Figure 4 , I-M).
Chn1
WT/WT and Chn1 WT/KI abducens explant outgrowth did not differ in high concentrations of GDNF (25 ng/ml GDNF+ immunoglobin FC [fragment, crystallizable] domain to control for recombinant FC-fusion proteins) ( Figure 6 , E, F, N, Q, and R). Thus, the addition of 25 ng/ml GDNF permitted reliable quantification of outgrowth in both forward and reverse ephrin signaling conditions, and permitted testing of the combinatorial effects from EphA4+GDNF stimulation on abducens outgrowth.
Chn1 WT/WT explants grown in ephrin-A5+GDNF displayed a significant reduction in maximum outgrowth compared with WT explants grown in FC+GDNF (Figure 6 , C, G, N, O, and Q), confirming that abducens explants are repelled by ephrin-A5. Chn1 WT/KI explants displayed significantly less maximum and total explant outgrowth in ephrin-A5+GDNF than Chn1
WT/WT explants ( Figure 6 , G, H, O, Q, and R), supporting the hypothesis that gain-of-function α2-chimaerin mutations increase ephrin-A5-mediated repulsion through canonical ephrin forward signaling. Notably, Chn1 KO/KO and Epha4 KO/KO abducens explants had maximum and total outgrowth in ephrin-A5+GDNF similar to that observed in FC+GDNF (Supplemental Figure 4 , N-W, and Figure 6 , E and N). The lack of responsiveness to ephrin-A5 was similar in the two knockouts, again suggesting that EphA4 is an upstream regulator of α2-chimaerinmediated repulsive signaling to ephrin-A5 in abducens neurons.
Abducens outgrowth differences were also noted with ephrin reverse signaling. Chn1
WT/WT abducens explants displayed significantly increased total outgrowth in EphA4+GDNF compared with FC+GDNF ( Figure 6 , E, I, N, P, and R), indicating that abducens neurons are capable of using ephrin reverse signaling to potentiate axon outgrowth in vitro. Remarkably Figure 5F ) and thinner nerve diameter near the orbit ( Figure 5G) Figure 5H ), presumably from enhanced nerve stalling. A transverse (top-down) view of abducens whole mount projections revealed wandering abducens projections in more detail ( Figure 5 , M-P, and Supplemental Figure 3 , D-G), demonstrating that the abducens nerve stalling and wandering phenotype in Chn1 KI/KI Epha4 KO/KO embryos ( Figure 5P and Supplemental Figure 3G ) is distinct from, but has features of, Epha4 KO/KO abducens nerve wandering ( Figure 5N and Supplemental Figure 3E ) and Chn1 KI/KI nerve stalling ( Figure 5O and Supplemental Figure 3F ). Finally, within area 3 at E16. 5 Figure 2B ): the abducens nerve failed to innervate the lateral rectus, which instead was innervated by aberrant branches of the oculomotor nerve ( Figure 5Q ). This area 3 phenotype was worse than that of Epha4 KO/KO embryos. In Epha4 KO/KO orbits, the lateral rectus muscle was appropriately innervated by the abducens nerve ( Figure 5R ), although occasionally the nerve appeared thinner than in WT embryos and had minor aberrant innervation of the lateral rectus from the oculomotor nerve (data not shown).
Thus, there appears to be a complex genetic interaction between α2-chimaerin and EphA4 driving the growth of the abducens nerve; in Chn1 WT/KI Epha4 KO/KO or Chn1 KI/KI Epha4 KO/KO embryos, some features of the abducens phenotype were rescued, some were worsened, and others were unaltered. These data support interactions between mutant α2-chimaerin and EphA4 signaling pathways that alter development of the abducens nerve differently than each individual allele. Additionally, similar to the slight abducens nerve phenotype modification seen in the Chn1 KO/KO Epha4 KO/KO cross, these results suggest other pathways could be involved either upstream of mutant α2-chimaerin or downstream of EphA4.
Abducens axons respond to ephrin forward and reverse signaling in explant cultures, and both responses are altered in Chn1
KI/ KI explants. In addition to traditional EphA4 repulsive forward signaling, whereby EphA4 acts as a neuronally expressed receptor to generate axon repulsion, EphA4 can also function as an attractant ligand for ephrin reverse signaling, working in coordination with glial cell-derived neurotrophic factor (GDNF) and its receptors to guide spinal motor neurons. In this system, the coordinated signaling between ephrin-A/Ret and GFRα1/Ret co-receptor pathways upon EphA4+GDNF co-ligand stimulation elicits an outgrowth response beyond that achieved solely by mesenchymal EphA4 signaling through an ephrin-A5/Ret complex or by GDNF signaling through its cognate GFRα1/Ret receptors (32). Chn1 WT/KI abducens explants. Interestingly, WT abducens explants grown in NGF (5 ng/ml) showed significantly increased outgrowth compared with conditions without growth factors (Figure 7 , F, H, L, and M, and Figure 6 , C and K). By contrast, Chn1
WT/KI abducens explants displayed significantly reduced outgrowth compared with WT controls, instead exhibiting outgrowth similar to that of explants without growth factor (Figure 7 , F-H, L, and M, and Figure 6 , C, D, and K). Higher concentrations of NGF (25 ng/ml) reduced outgrowth of WT explants to control levels, such that the differences between WT and mutant abducens outgrowth were eliminated (Figure 7 , I-M, and Figure 6 , C, D, and K). These experiments reveal that both Ret and p75
NTR have the potential to be used as ephrin co-receptors in abducens neurons.
Neuronal and mesenchymal Epha4 conditional knockouts reveal abducens phenotypes that differ from each other and from Epha4
KO/KO . Our in vitro explant data support the hypothesis that the complex genetic interaction between α2-chimaerin and EphA4 in abducens could result, at least in part, from the recruitment of α2-chimaerin in both ephrin forward and reverse signaling. Thus, we conditionally knocked out Epha4 selectively in motor neurons or in the mesenchyme surrounding the peripheral nerve to evaluate the outgrowth of abducens axons with loss of ephrin forward or reverse signaling, respectively. We selectively removed EphA4-mediated ephrin forward signaling using an Isl Cre/+ mouse (35) , in which Cre is present in Isl-expressing cranial and spinal motor neurons and not in the surrounding mesenchyme (Supplemental Figure  5A) Figure 5B) . Next, to determine the effect of removing EphA4-mediated ephrin forward signaling in motor neurons, we analyzed Figure 5N , and Supplemental Video 7). Therefore, selectively removing Epha4 from motor neurons results in an abducens phenotype distinct from Epha4 KO/KO . These data alone support a role for both EphA4-mediated ephrin forward and reverse signaling in abducens development.
In an analogous approach, to directly investigate the role of EphA4-mediated ephrin reverse signaling in abducens development, we knocked out mesenchymal Epha4 expression by generating Epha4 fl/fl Twist2 Cre/+ mice. Twist2 Cre had broad expression in the E11.5 mesenchyme through which the abducens and other cranial and spinal nerves grow, but was absent from the brain, hindbrain, and spinal cord (36) (Supplemental Figure 5C ). Epha4 expression was greatly reduced in the mesenchymal tissue through which the abducens nerve projects in Epha4 fl/fl Twist2 Cre/+ embryos, but was instead had outgrowth similar to that in FC+GDNF (Figure 6 , E, F, I, J, N, and P-R). These results indicate that mutant α2-chimaerin is recruited downstream of ephrin reverse signaling to attenuate the normal increase in abducens outgrowth that is seen upon addition of EphA4 in WT abducens cultures. We cultured Chn1 KO/KO explants to investigate whether α2-chimaerin was necessary for ephrin reverse signaling. We found that when grown in EphA4+GDNF, outgrowth increased to a similar extent in Chn1 KO/KO and WT explants (Supplemental Figure 4 , X-BB). Thus, while WT α2-chimaerin is not necessary for ephrin reverse signaling in abducens motor neurons, mutant α2-chimaerin generates an alternate, gain-of-protein-function that dampens abducens outgrowth in response to ephrin reverse signaling, which may support the recruitment of α2-chimaerin via an indirect feedback loop.
Ret and p75 NTR are candidate co-receptors to mediate ephrin reverse signaling upstream of mutant α2-chimaerin in abducens neurons. While the involvement of α2-chimaerin in ephrin forward signaling has been previously characterized (12) (13) (14) (15) 29) , to our knowledge the role of mutant α2-chimaerin in ephrin reverse signaling is novel. Ephrin-A lacks an intracellular signaling domain and requires a co-receptor for reverse signaling. In addition to the Ret/GDNF/GFRα1 spinal motor neuron signaling pathway described above (32), p75
NTR has been shown to act as an ephrin-A co-receptor in retinal ganglion cells (RGCs) (33) .
The small number of abducens neurons precludes biochemical pathway analysis to directly ascertain whether Ret and/or p75 NTR are recruited for ephrin reverse signaling upstream of α2-chimaerin in mutant abducens neurons. Thus, to gain initial insight into these pathways, we harnessed the Sholl analysis method to characterize outgrowth of Chn1 WT and mutant abducens explants upon stimulation of Ret or p75 NTR pathways. From our EphA4+GDNF abducens Sholl analysis ( Figure  6 , I, J, and P-R), it appears likely that Ret is used as a co-receptor for ephrin reverse signaling in abducens neurons. To further investigate the contribution of Ret signaling upstream of mutant α2-chimaerin in abducens neurons, we cultured explants in a low concentration of GDNF (1 ng/ml), as previous studies have indicated that the exogenous concentration of GDNF is important for regulating robust GDNF signaling (34) . Intriguingly, we found that at low GDNF concentrations there was a significant difference in outgrowth between WT and mutant explants. WT abducens explants trended toward increased outgrowth in low GDNF concentrations compared with conditions without growth factor (FC alone), whereas Chn1 WT/KI explants showed outgrowth similar to that without growth factor and significantly reduced outgrowth compared with WT ( Figure 7 , A-E, and Figure 6K) . Thus, the lower concentration of GDNF reveals altered activity of mutant α2-chimaerin downstream of GDNF/Ret signaling. Differences between WT and mutant explants were eliminated at higher GDNF concentrations, as both showed significantly increased outgrowth compared with control ( Figure 7 , D and E, and Figure  6 , K and N). Future pathway analyses will elucidate the signaling mechanisms of mutant α2-chimaerin either directly or indirectly downstream of ephrin-A/Ret receptor signaling.
To ascertain whether p75 NTR -mediated co-receptor pathways might also activate mutant α2-chimaerin to alter abducens outgrowth in vitro, we added NGF as a p75
NTR ligand to WT and ar nerve projections crossed the dorsal midline ( Figure 9H ). Thus, expression indicates it is possible for trochlear neurons to use bidirectional ephrin signaling via mutant α2-chimaerin, and we returned to the modified Sholl approach to investigate this possibility. Chn1 WT/WT and Chn1 WT/KI trochlear explants cultured under control conditions did not have significantly different outgrowth; thus, α2-chimaerin did not appear to be constitutively hyperactive at baseline ( Figure 9I and Supplemental Figure 6, A and B) . Outgrowth of Chn1 WT/WT trochlear explants grown in ephrin-A5+GDNF was indistinguishable from outgrowth in FC+GDNF (Figure 9, I , J, and L, and Supplemental Figure 6 , A and C). Chn1 WT/KI explants had a modest, but significant, reduction in outgrowth in ephrin-A5+GDNF compared with WT explants (Figure 9 , J and L, and Supplemental Figure 6, C and D) . Thus, in the correct circumstances, hyperactive α2-chimaerin can be recruited downstream of ephrin forward signaling to alter trochlear outgrowth. Outgrowth of WT trochlear explants grown in EphA4+GDNF did not significantly differ from that in FC+GDNF ( Figure 9 , I, K, and L, and Supplemental (Figure 9 , B, O, and P), and thus the Chn1 KI trochlear phenotype was largely unaltered by the Epha4 KO allele. Thus, distinct from the use of bidirectional ephrin signaling upstream of α2-chimaerin in abducens neurons, mutant α2-chimaerin likely acts downstream of non-ephrin-mediated pathways to modulate trochlear nerve development.
Chn1 KI/KI embryonic mice display first cervical spinal (C1) nerve abnormalities, which are restored by removing EphA4. Finally, we examined non-ocular motor neuron populations in E11.5 Chn1 KI/KI embryos and found a selective defect in the projection of the first cervical spinal (C1) nerve. In Chn1 WT/WT E11.5 mice, C1 exited the spinal cord ventrally to meet with projections of the hypoglossal nerve ( Figure 10A and Supplemental Video 1). In Chn1 WT/KI and Chn1 KI/KI embryos, C1 exited the brainstem appropriately, but turned dorsally toward the dermomyotome with variable bilateral penetrance ( Figure 10B and Supplemental Video 2).
By contrast to Chn1 KI embryos, C1 nerve projections were similar to WT controls in Chn1 KO (Figure 10 , C-F, and Supplemental Figure 7, A and B) . Therefore, we asked whether C1 neurons are similar to trochlear neurons and do not rely on WT α2-chimaerin or EphA4 for proper development. C1 neurons/nerve bundles expressed Chn1, Epha4, and ephrin-A5 (Supplemental Figure 2C and Figure 10 , G-J), and Epha4 was expressed in the mesenchyme through which C1 axons extend and target in E11.5 embryos (Figure 10I) , demonstrating proper expression that could support bidirectional ephrin signaling. Thus, we cultured Chn1 WT and preserved in the abducens nucleus and CNS (Supplemental Figure 5, D-G Figure 8I and Figure 5E ), which initially wandered in the mesenchymal area adjacent to the hindbrain exit before completely stalling in the mesenchyme (Figure 8 , E-H, Supplemental Figure 5 , J and K, Figure 5N , and Supplemental Video 8). This led to a dramatic reduction in abducens length and complete lack of both abducens innervation near the orbit and aberrant tracking with the facial nerve (Figure 8 , J-L, Figure 5 , F-H, and Supplemental Figure 5M) .
Together, these in vivo data support that EphA4 is used as a receptor and ligand for ephrin forward and reverse signaling to guide abducens nerve development. Moreover, our in vitro data indicate that WT and mutant α2-chimaerin modulate abducens neuron growth downstream of ephrin forward signaling, while mutant (but not WT) α2-chimaerin modulates abducens neuron growth downstream of ephrin reverse signaling. We anticipate that the complex abducens phenotype in Chn1
WT/KI Epha4 KO/KO and Chn1 KI/KI Epha4 KO/KO embryos arises, at least in part, from recruitment of mutant α2-chimaerin downstream of both ephrin forward and reverse signaling.
Chn1 KI/KI embryonic mice display trochlear nerve abnormalities, which are unaltered by removing EphA4. Individuals with DRS harboring CHN1 mutations can also have mild vertical eye movement abnormalities (3, 9) . Thus, we investigated whether DRS-mutant Chn1 in mouse alters oculomotor or trochlear nerve development. Notably, while we found aberrant innervation by the oculomotor nerve of the lateral rectus muscle within the orbit secondary to absence of the abducens nerve (Figure 2, A and B) (24) , its trajectory was otherwise indistinguishable from WT (Figure 1, D , E, G, and H, and Supplemental Videos 1 and 2). Thus, our results with endogenous mutant Chn1 expression differ from the reported oculomotor stalling that follows overexpression of mutant Chn1 in chick and zebrafish (3, 18, 23) . We did, however, find errors in trochlear nerve projection in Chn1 KI/KI embryos at E11.5, consistent with hypoplasia of its target, the superior oblique muscle, reported in some affected individuals (4, 9) .
In E11.5 WT embryos, trochlear axons projected dorsally, crossed the midline in the tectum, exited the brainstem, and fasciculated into a single nerve bundle that projected anteriorly toward the contralateral superior oblique ( Figure 9A and Supplemental Video 1). In E11.5 Chn1
WT/KI and Chn1 KI/KI embryos, trochlear axons crossed the midline and exited dorsally as in WT embryos, but the axons formed multiple fascicles instead of one nerve bundle, most of which extended appropriately toward the contralateral orbit, but some of which turned back and misprojected toward the ipsilateral orbit ( Figure 9B and Supplemental Video 2).
Trochlear nerve projections in Chn1 KO/KO and Epha4 KO/KO embryos were unaffected ( Figure 9 , C and D, and Supplemental Videos 3 and 5), suggesting that WT α2-chimaerin and EphA4 may not be necessary for trochlear nerve guidance, even though mutant α2-chimaerin altered trochlear nerve development. However, trochlear neurons/axons expressed Chn1, Epha4, and ephrin-A5 (Supplemental Figure 2A and Figure 9 , E-G), and ephrin-A5 was expressed in a strong graded pattern in the midbrain tectum near where trochle- (12, 14, 15, 29) . Thus, an increase or decrease in α2-chimaerin activity has unique consequences on different neuronal cell types, which may lend insight into its specific functions in different motor neuron populations.
EphA4-mediated ephrin forward and reverse signaling are both critical for proper abducens guidance during embryonic development. Ephrin forward and reverse signaling has been characterized as guiding the axonal projections of limb-innervating motor neurons (32, 38, 39) , and α2-chimaerin is known to act downstream of ephrin forward signaling in several neuronal types (12) (13) (14) (15) , including limb motor neurons (29) . We expand on these findings to define the involvement of EphA4-mediated ephrin forward and reverse signaling in abducens nerve development and in a human developmental disorder. We find that selective reduction of ephrin forward signaling by knocking out EphA4 in motor neurons reduces successful lateral rectus targeting of the abducens nerve, perhaps because axons lose the appropriate level of repulsion from incorrect targets. Selectively reducing ephrin reverse signaling by knocking out EphA4 in the mesenchyme causes severe abducens stalling, likely because the nerve is not properly recruited through the mesenchyme toward its target. Both of these abducens phenotypes are more severe than the complete Epha4 KO/KO ; therefore, disrupting the balance of attraction or repulsion alone during axon navigation can be more detrimental than interfering with both simultaneously.
α2-Chimaerin and EphA4 exhibit varied genetic interactions in different motor neuron populations. We have identified a complex genetic interaction between Epha4 and Chn1
KI in abducens nerve development, which we find can be explained, in part, by the role of mutant α2-chimaerin downstream of both ephrin forward and reverse signaling. Intriguingly, abducens, trochlear, and C1 nerve phenotypes are reversed to varying degrees in Chn1 KI/KI Epha4 KO/KO mice, which our in vitro experiments demonstrate can be partially accounted for by the different recruitment of mutant α2-chimaerin in ephrin forward and reverse signaling in these motor neuron subtypes. Our data provide insight into potential mechanisms that generate selective vulnerability of abducens neurons to non-constitutively hyperactivating α2-chimaerin mutations. We propose four nonexclusive scenarios to account for the varying degrees of EphA4/α2-chimaerin genetic interaction in abducens, trochlear, and C1 neurons:
First Because we found that C1 neurons use repellent ephrin forward signaling and not attractant ephrin reverse signaling upstream of α2-chimaerin in vitro, we asked whether removing Epha4 would rebalance the activity of mutant α2-chimaerin in Chn1 KI Figure 10P ), demonstrating that removal of Epha4 reverses the Chn1 KI/KI C1 guidance defects and restores normal C1 guidance. These in vitro and in vivo data support that aberrant C1 turning in Chn1 KI/KI embryos is mediated through ephrin forward signaling and indicate it is possible to restore the normal growth of Chn1 mutant projections by removing key upstream repellent receptors.
Discussion
Chn1
KI/KI mice reveal abducens guidance defect as a primary etiology of DRS. Neuronal pathfinding is essential for establishing functional circuits to elicit normal behavior. We report that CHN1 mutations identified in human patients, when modeled in the mouse, cause primary abducens nerve stalling within the mesenchyme, preventing the abducens nerve from contacting the lateral rectus muscle. Within the orbit, the oculomotor nerve sends stereotypical aberrant branches to misinnervate the lateral rectus, which has recently been shown to also occur secondarily to the absence of abducens motor neurons (24) . Together, these studies strongly indicate that DRS results from a primary developmental insult to the abducens nucleus or nerve that prevents its innervation of the lateral rectus. Following this innervation failure, the oculomotor nerve secondarily substitutes innervation to the lateral rectus.
The Duane syndrome phenotype arises during early embryonic development at stages that correspond with approximately 5 weeks human gestation (37) , and the early embryonic onset likely precludes practical therapeutic intervention. However, mechanisms that guide opportunistic innervation of the lateral rectus by the oculomotor nerve may provide insights into principles of misinnervation that are involved in other disorders, such as inappropriate facial nerve innervation following injury or surgery. More- Whole mount embryo staining. E11.5 embryos were fixed in 4% PFA and prepared as previously described (42) . Whole embryos were stained with primary 1:500 mouse anti-neurofilament (DSHB) and 1:500 rabbit anti-GFP (Invitrogen); secondary 1:1,000 goat antimouse Alexa Fluor 546 (Invitrogen) and 1:1,000 goat anti-rabbit Alexa Fluor 488 or 647 (Invitrogen). Embryos were cleared with 1 part benzyl alcohol:2 parts benzyl benzoate (Sigma-Aldrich) and imaged using a Zeiss LSM710 confocal microscope. Images were processed in 3D using Imaris (Bitplane) to identify similar z-planes between embryos. See Supplemental Methods for measurement parameters (27) .
Orbital dissections. E16.5 Isl
MN
-GFP-positive mouse embryos from the indicated genetic crosses were prepared as previously described (24 (11, 16, 18) ; it will be of future interest to determine the contribution of these and other guidance pathways in Chn1 KI/KI phenotypes. Third, distinct receptor composition in different neuronal subtypes may mediate integration of different ligands that act through α2-chimaerin to yield different phenotypes. We show that abducens neurons use ephrin reverse signaling upstream of mutant α2-chimaerin in vitro to mediate increased outgrowth. The signaling mechanisms underlying this phenomenon remain an area for further investigation, as it appears that α2-chimaerin may not normally act downstream of ephrin reverse signaling, but rather is recruited under gain-of-function mutant conditions. Similar to reports in limb motor neurons (32) , ephrin-A5 could use Ret as a co-receptor for reverse signaling in concert with GFRα1/Ret signaling to mediate potentiated outgrowth of abducens neurons in response to EphA4 and GDNF ligands. In this case, DRS-mutant α2-chimaerin may misregulate signaling pathways downstream of Ret to dampen increased outgrowth. Alternatively, if abducens neurons use p75 NTR as a co-receptor for ephrin reverse signaling similar to RGCs (33), mutant α2-chimaerin may act downstream of p75 NTR to enhance axon repulsion. Ret and p75 NTR co-receptor pathways could be recruited simultaneously in abducens neurons to modulate ephrin reverse signaling, thus combining elements of RGC and limb motor neuron axon guidance and accounting for an additional layer of phenotype specificity and complexity.
Last, expression of different cytoskeletal regulatory pathways (i.e., RacGAPs/GEFs) in specific motor neuron populations may modulate the signaling contribution of α2-chimaerin. The varied expression and recruitment of diverse RacGAP/GEF pathways in different motor neuron populations may further influence phenotype rescue and selective vulnerability.
Further investigation into the mechanisms underlying the selective ephrin-and non-ephrin-mediated signaling pathways upstream of α2-chimaerin may lead to the identification of additional genetic contributions to DRS.
Mutant α2-chimaerin informs the complexity of axon guidance signaling pathways in neuronal development. Our data highlight the importance of investigating molecular mechanisms in a cell type-specific manner. Despite the technical challenges posed by the limited number of abducens motor neurons that project to a discrete muscle target (40), we are able to combine in vivo genetic interaction studies and motor neuron subtype-specific in vitro cultures to assess the implications of altered signaling pathways on abducens development. We find that even this simple neuronal circuit uses intricate guidance pathways to establish connectivity, which can serve as a model from which to investigate the breadth of signaling complexity that exists between various guidance receptors during development. By using a gain-of-function dard threshold was applied to images. Explant body was outlined manually in Fiji, concentric circles were drawn using a macro at 20-μm intervals, and intersecting axons were counted. WT controls were present in each replicate within every condition, and different protein combinations were compared within at least one experiment per group. Individual samples were graphed, then averaged across experiments within each condition to obtain final outgrowth curves. Outgrowth calculations are discussed in Supplemental Methods.
Statistics. All data were analyzed and graphed using SPSS software (IBM). Statistical methods are provided in each figure legend and include one way ANOVA with Tukey's or Dunnett's test and unpaired two tailed t test. P < 0.05 was considered statistically significant, except where indicated based on Bonferroni correction. Graphs represent mean ± SEM.
Study approval. All animal work was performed in compliance with protocols approved by the Boston Children's Hospital Institutional Animal Care and Use Committee.
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